Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer

Journal of Clinical Oncology

Volumn 18, Issue 8, 2000, Pages 1740-1747

  Chang, Ting Chang ^a   Lai, Chyong Huey ^a   Hong, Ji Hong ^a   Hsueh, Suei ^a   Huang, Kuan Gen ^a   Chou, Hung Hsueh ^a   Tseng, Chih Jen ^a   Tsai, Chien Sheng ^a   Chang, Joseph T ^a   Lin, Cheng Tao ^a   Chang, Huei Hsin ^a   Chao, Pei Jung ^a   Ng, Koon Kwan ^a   Tang, Simon Guo Jeng ^a   Soong, Yung Kwei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; MANNITOL; METOCLOPRAMIDE; SEROTONIN 3 ANTAGONIST; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION INJURY; SKIN TOXICITY; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

EID: 17744405413     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.8.1740     Document Type: Article

References (42)

1. Pettersson F (ed): Carcinoma of the cervix, in Annual Report on the Results of Treatment in Gynecological Cancer. Stockholm, Sweden, International Federation of Gynecology and Obstetrics, 1988, pp 29-33
2. Burghardt E, Pickel H: Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52:138-145, 1978
3. Chung CK, Nahhas WA, Stryker JA, et al: Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138:550-556, 1980
4. Piver MS, Chung WS: Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46:507-510, 1975
5. Alvarez RD, Soong SJ, Kinney WK, et al: Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 36:130-135, 1989
6. Delgado E, Bundy B, Zaino R, et al: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study, Gynecol Oncol 38:352-357, 1990
7. Perez CA, Grigsby PW, Camel HM, et al: Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 31:703-716, 1995
8. Durrance FY, Fletcher GH, Rutledge FN: Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus. AJR Radium Ther Nucl Med 106:831-838, 1969
9. Gallion HH, van Nagell JR Jr, Donaldson ES, et al: Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 56:262-265, 1985
10. Rutledge FN, Wharton JT, Fletcher GH: Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix. Cancer 38:596-602, 1976
11. Prestayko AW, D'Aoust JC, Issell BF, et al: Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 6:17-39, 1979
12. Vogl SE, Moukhtar M, Calanog A, et al: Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum (II) (BOMP). Cancer Treat Rep 64:1005-1007, 1980
13. Alberts DS, Martimbeau PW, Surwit EA, et al: Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials 4:313-316, 1981
14. Hall DJ, Diasio R, Goplerud DR: cis-Platinum in gynecologic cancer: II. Squamous cell carcinoma of the cervix. Am J Obstet Gynecol 141:305-308, 1981
15. Thigpen T, Shingleton H, Homesley H, et al: Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Cancer 48:899-903, 1981
16. Daghestani AN, Hakes TB, Lynch G, et al: Cervix carcinoma: Treatment with combination cisplatin and bleomycin. Gynecol Oncol 16:334-339, 1983
17. Bloch B, Nel CP, Kriel A, et al: Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer. Cancer Treat Rep 68:891-893, 1984
18. Friedlander ML, Atkinson K, Coppleson JV, et al: The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study. Gynecol Oncol 19:1-7, 1984
19. Jobson VW, Muss HB, Thigpen JT, et al: Chemotherapy of advanced squamous carcinoma of the cervix: A phase I-II study of high-dose cisplatin and cyclophosphamide - A pilot study of the Gynecologic Oncology Group. Am J Clin Oncol 7:341-345, 1984
20. Bonomi P, Blessing JA, Stehman FB, et al: Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 3:1079-1085, 1985
21. Coleman RE, Clarke JM, Slevin ML, et al: A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 27:52-54, 1990
22. Wertheim MS, Hakes TB, Daghestani AN, et al: A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 3:912-916, 1985
23. Lai CH, Lin TS, Soong YK, et al: Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 35:193-198, 1989
24. Killackey MA, Boardman L, Carroll DS: Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer. Gynecol Oncol 49:377-379, 1993
25. Curtin JP, Hoskins WJ, Venkatraman ES, et al: Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial. Gynecol Oncol 61:3-10, 1996
26. Thomas GM: Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix. J Natl Cancer Inst Monogr 21:77-83, 1996
27. Sardi JE, di Paola GR, Cachau A, et al: A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 25:139-149, 1986
28. Sardi J, Sananes C, Giaroli A, et al: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38:486-493, 1990
29. Sardi JE, di Paola GR, Giaroli A, et al: Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri. Gynecol Oncol 31:256-261, 1988
30. Lai CH, Hsueh S, Chang TC, et al: Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 64:456-462, 1997
31. Chang HC, Lai CH, Chou PC, et al: Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 30:281-285, 1992
32. Chang TC, Hsieh FS, Lai CH, et al: Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis. Cancer Chemother Pharmacol 37:279-285, 1996
33. Hong JH, Tsai CS, Chang JT, et al: The prognostic significance of pre- and post-treatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys 41:823-830, 1998
34. Hsu WL, Wu CJ, Jen YM, et al: Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: A nonrandornized comparison of treatment results. Int J Radiat Oncol Biol Phys 32:1425-1431, 1995
35. Tsai CS, Lai CH, Wang CC, et al: The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 75:328-333, 1999
36. National Cancer Institute: Guidelines for Reporting Adverse Drug Reactions. Bethesda, MD, National Cancer Institute, Division of Cancer Treatment, Cancer Therapy Evaluation Program, 1988
37. Lachin JM, Matts JP, Wei LJ: Randomization in clinical trials: Conclusions and recommendations. Control Clin Trials 9:365-374, 1988
38. Poppenborg H, Munstermann G, Knupfer MM, et al: Cisplatin induces radioprotection in human T98G glioma cells. Anticancer Res 17:1131-1134, 1997
39. Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161, 1999
40. Sardi JE, Giaroli A, Sananes C, et al: Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results. Gynecol Oncol 67:61-69, 1997
41. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143, 1999
42. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153, 1999